LinkedIn Profile

John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for Human Genome Research to work on the Human Genome Project. He spent two years at the Salk Institute and two years at Stanford University working \ at the interface of genomics and computational biology. In 1997 he joined the faculty of The Institute for Genomic Research (TIGR) where his focus began to shift to understanding what was encoded within the human genome. Since joining the faculties of the Dana-Farber Cancer Institute and the Harvard School of Public Health in 2005, his work has focused on decoding and modeling the networks of interacting genes that dr\ ive disease. In 2011 he and partner Mick Correll launched GenoSpace to facilitate genomic data analysis and interpretation, focused on accelerating research and delivering relevant and actionable solutions for precision medicine. John and GenoSpace were recognized by the White House as ?Open Science Champions of Change? for developing tools to make genomic data accessible to scientists, physicians, and the general pub\ lic.

Mudit is a serial entrepreneur and technologist and believes in using technology for solving big problems. Mudit worked at McKinsey & Company?s healthcare practice and founded Vdopia, one of India?s largest online video ad networks. Nowadays, he runs AnalyticsMD, a web-based software service product that provides data-driven operational insights to front-line hospital managers to improve patient care and reduce costs \ by improving patient flow, staffing and bed capacity. Mudit grew up in New Delhi. He received a Bachelor?s Degree in Electrical Engineering from IIT-Madras and received an MBA and Master?s Degree in Engineering from Stanford University

LinkedIn Profile

Catherine Ball is a genomic scientist who has annotated and mined the genomes of various organisms and created resources to help other scientists do the same. As a pioneer in data analysis resources for high-throughput biomedical technologies, Dr. Ball has used ?big data? to shed light on diverse research topics, from the biology of infectious organisms to the mechanisms involved in cell division and cancer. She recei\ ved a Ph.D. in Molecular Biology from UCLA and devoted several years to research in the Departments of Genetics and Biochemistry at Stanford University before establishing the genomics team at AncestryDNA.

Nicholas (Nick) Naclerio joined Illumina in 2010 and is responsible for all corporate business development activities, including strategic planning, licensing, corporate partnerships, and acquisitions. In addition, he leads Illumina?s Enterprise Informatics business which enables the storage, analysis, understanding and sharing of genomic and phenotypic information. Before joining Illumina, Nick co-founded and was the Executive Chairman of Quanterix, an emerging diagnostics company based on a novel single molecule detection platform. Previously, Nick was Executive Chairman of True Materials and CEO of ParAllele BioScience, life science tools firms that were both acquired by Affymetrix, and was the founding Vice President & General Manager of Motorola Life Sciences. He also held l\ eadership roles at Zyomyx Inc., Motorola Ventures, the Defense Advanced Research Projects Agency (DARPA), and the U.S. Air Force. Additionally, Nick has served on a number of corporate and institutional boards, including Boreal Genomics, the SNP Consortium, Genometrix, Clinical Microsensors, Orchid Bioscience, and SEMATECH. Nick received a B.S. (summa cum laude) in Electrical Engineering and Computer Science from Duke University, a Winston Churchill Fellowship in Materials Science to Cambridge University, and a Ph.D. in Electrical Engineering from the University of Maryland.